Medidata Revenue, Profits - MDSO Annual Income Statement

Add to My Stocks
$65.02 $2.05 (3.06%) MDSO stock closing price Mar 22, 2018 (Closing)

Looking at financial statements, along with the Medidata stock price, it's management, its economic moat, and industry competitors forms an important part of fundamental analysis. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $463.38M for 2016 impacts the MDSO stock. Investors typically check year over year or quarter over quarter revenue growth. Revenue for year 2016 is $463.38M and has increased from $392.5M year on year as is evident when you compare the latest figures in the latest Medidata profit and loss statement with those of the prior corresponding period. Also see Medidata assets and Medidata free cash flow for a complete valuation of MDSO stock.

View revenue and profit details for latest and last 10 financial years.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Medidata Revenues or Net Sales
Cost Of Goods Sold (COGS)112.6M89.78M84.92M69.9M62.66M52.83M52.24M49.97M50.44M
Medidata Gross Profit
Research & Development Expense112.59M92.31M71.75M51.2M42.27M29.56M25.77M22.53M19.34M
Selling General & Admin Expense187.96M181.16M158.33M131.85M85.51M79.5M65.1M59.11M51.66M
Income Before Depreciation Depletion Amortization50.2M29.23M20.06M23.88M27.89M22.55M23.3M8.77M-15.72M
Depreciation Depletion Amortization---------
Non Operating Income4.39M2.73M1.81M------
Interest Expense17.28M16.19M15.36M5.92M---1.85M1.93M
Medidata Pretax Income
Provision for Income Taxes8.33M2.6M-1.72M10.04M-16.43M-1.85M-
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations28.98M13.16M6.09M16.66M18.02M39.39M22.81M5.18M-18.27M
Extraordinary Items & Discontinued Operations---------
Medidata Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS57.25M56.54M55.25M54.12M50.94M49.31M48.12M41.47M13.59M
Average Shares used to compute Basic EPS55.49M53.72M52.56M51.06M49.09M47.29M45.92M29.73M13.59M
Income Before Nonrecurring Items38.11M21.46M17.41M20.15M20.13M28.47M24.28M7.01M-17M
Income from Nonrecurring Items-9.13M-8.29M-11.32M-3.49M-2.11M10.93M-1.46M-1.83M-1.27M
Medidata Earnings Per Share Basic Net
Medidata Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.670.380.310.370.400.580.510.17-1.29
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Medidata stock analysis involves checking at least a few of the important things like:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Medidata revenue chart implies that the company is growing. It has been the case with Medidata. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $28.98M for MDSO stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The MDSO financials along with Medidata historical stock prices provide a lot of details about the firm.

Medidata Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield